Improved in vitro synthesis system

Details for Australian Patent Application No. 2002247274 (hide)

Owner INVITROGEN CORPORATION

Inventors Longo, Mary C.; Chatterjee, Deb K.

Agent Houlihan2

Pub. Number AU-A-2002247274

PCT Pub. Number WO2002/072890

Priority 60/273,827 08.03.01 US

Filing date 7 March 2002

Wipo publication date 24 September 2002

International Classifications

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C12P 019/34 Preparation of compounds containing saccharide radicals

C07H 021/02 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 021/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

20 March 2003 Application Open to Public Inspection

  Published as AU-A-2002247274

2 October 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002247275-COLORIMETRIC GENETIC TEST FOR CLINICALLY SIGNIFICANT TNF POLYMORPHISM AND METHODS OF USE THEREOF

2002247273-Benzimidazole compounds for modulating ige and inhibiting cellular proliferation